Swissmedic posts 7.3M francs surplus for 2006

Switzerland's drug approval regulator, Swissmedic, has issued its annual report for 2006, which includes the revelation that the agency made a 7.3 million Swiss francs ($5.9 million) surplus. Swissmedic also reported a reorganization program launched in response to a management review in May last year. The regulator's chairman, Christine Beerli, explained the better-than-forecast figures for Swissmedic's 70.5 million-franc turnover, by referring to raised user fees and efficiency gains.